Kunin Audrey 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Sep 16, 2022
Insider Transaction Report
Form 4
Kunin Audrey
Chief Product Officer
Transactions
- Sale
Common Stock
2022-09-14$0.16/sh−291,368$46,094→ 208,632 total(indirect: See footnote)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.1565 to $0.1605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.